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 Traumatic Brain injury (TBI) is a considerable health care 
problem
1-3
 and is one of the most common causes of death.Its 
incidence is rising at large proportions in regions with rapidly 
increasing motorization because of industrialized development. The 
incidence varies from 67 to 317 per 100000 individuals and mortality 
rates range from around 4-8% for moderate injury to approximately 
50% with severe head injury.
4 
 The symptoms of TBI can be various depending on the extent of 
damage to the brain. The outlook for patients with mild TBI is 
generally a good recovery, while patients with a severe TBI have a 
substantial risk to die. Predicting outcome for very good or very 
severe patients is therefore rather easy. However, for severe and 
moderate TBI patients the outcome is not so easy to predict, while 
such predictions would be helpful in supporting clinical decision 
making, providing realistic and evidence based expectations to 
relatives and care givers, as well as in clinical research. 
 Any ideal prediction score or model should be easy to apply, 
with high sensitivity and specificity rates irrespective of the 
management protocol, its time and place of application. Several 
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prospective and retrospective studies have been done to derive a 
baseline predictive model for patients in the intensive care unit in 
general or specific to traumatic brain injury
5
. 
 This thesis is aimed at comparing the various head injury 
prognostic scales so that risk prediction can be applied to patients with 
moderate and severe traumatic brain injury. This will help us to obtain 




































AIM OF THE STUDY 
 
1. The application of various prognostic scales on outcome of 
moderate and severe traumatic brain injury patients. 
2. To compare the sensitivity, specificity and efficacy of the 















REVIEW OF LITERATURE 
 
Traumatic Brain Injury is brain damage resulting from external forces, 
due to direct impact, rapid acceleration or deceleration
6. 
 
PATHOPHYSIOLOGY OF TRAUMATIC BRAIN INJURY 
   
    Pathophysiology 
      
 
Primary injury     Secondary Injury 
Includes direct tissue injury   Includes tissue injury minutes to 
from traumatic mechanism hours after primary injury.  
E.g.: Contusion, Hemorrhage,    Ischemia from elevated intracranial 
Shearing, etc   pressure and/or systemic injury. 
     Metabolic Toxins e.g.: release of  
                                                 excitotoxic transmitters, free                           






Speciﬁc Pathophysiology of traumatic brain injury 
1. Cerebral blood ﬂow perfusion defects- hypo and hyper perfusion 
2. Cerebrovascular dysautoregulation and CO2-reactivity 
3. Cerebral vasospasm 
4. Cerebral metabolic dysfunction 
5. Excitotoxicity and oxidative stress. 
6. Cerebral oxygenation 
7. Edema 
 
Traumatic Brain Injury Classification: 
Clinical assessment of TBI patients can be done using GLASGOW 
COMA SCALE 
The GCS was devised by Teasdale and Jennett in 1974.It is a practical 
scale to assess the depth of coma objectively. The adult GCS can be 
used for children >5years of age. 
The parameters assessed in GCS are: 
1. Eye Response 
2. Verbal Response 





EYE OPENING:  
Spontaneous 4 
To Verbal Commands 3 
To Pain 2 
None 1 
BEST MOTOR RESPONSE:  
Obeys Verbal Commands 6 
Localizes Pain 5 
Flexion /Withdrawal 4 
Flexion /Abnormal(decorticate) 3 
Extension(decerebrate) 2 
None 1 
BEST VERBAL RESPONSE:  
Oriented, Conversing 5 
Disoriented , Conversing 4 
Inappropriate Words 3 
Incomprehensible Sounds 2 
None 1 
TOTAL : 3-15 





Based on Glasgow Coma Scale , TBI can be classified as follows
7
 
GCS 3-8 Severe TBI 
GCS 9-13 Moderate TBI 
GCS 14-15  Mild TBI 
 
All TBI patients require CT scan imaging of brain. 
Marshall CT Classification 
Assessment of the extent of structural damage of brain is commonly 
performed according to the Marshall CT classification given by 
Marshall et al in 1991 as a descriptive system that focused on the 




Diffuse injury II Diffuse Injury III 
(swelling) 













-Midline shift of 0-
5mm 
-No mass lesion >25cc 
- Midline shift 
>5mm 
-no mass lesion 
>25cc 
 




 A different approach to classifying patients is by prognostic 
risk. Recently, due to the large patient groups, well corroborated 
models have become available to aid this approach.
 
 All these approaches to classification are characterized by some 
form of scoring of severity. 
INCIDENCE 
 The overall worldwide incidence of TBI is 235 per 100000 
population reported by Tagliaferri and colleagues.
9 
 National level data in India is not available for TBI as in many 
developed countries. The only epidemiological study undertaken in 
Bangalore by Gururaj et al at NIMHANS has revealed an incidence of 
150 per 100000 populations. 
 Patients between 15-24years of age, male gender are at the 
highest risk with a second peak for both men and women older than 
65yrs of age. 
ETIOLOGY OF TRAUMATIC BRAIN INJURY
10, 11 
The main causes of brain trauma are  
a. Transportation incidents (50%) 
b. Falls (21%) 
c. Gunshot wounds 
d. Assaults or other violent trauma (12%) 
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e. Sports and recreation related TBI (10%) 
ETIOLOGY OF TRAUMATIC BRAIN INJURY 
 
 
FACTORS AFFECTING THE PROGNOSIS OF Traumatic 
brain injury: 




4. Mechanism of injury 







Motor vehicle accidents 
Falls 
Assaults and violence 









 Age plays a crucial part in the prognosis of TBI. Age is a 
variable which is not altered by observer measurement and hence 
should be documented on admission. It has a bimodal distribution 
incidence in traumatic brain injury. The young adult males constitute 
the larger peak in the incidence followed by the elderly population 
which constitutes the next smaller peak.  
 Boto GR et al conducted a study in 2006 and found a step wise 
threshold for risk after the age of 65years. 
 Chesnut et al published an article comparing the association 
between age, outcome after head injury. The study concluded a 
positive association between advanced age and poor outcome, 
suggesting a threshold age of 60years. 
 Age strongly influences the mortality and morbidity. Many 
studies have proven that children do better than adults with TBI. Age 





 Many studies have found that there is no correlation between 
gender and outcome after traumatic brain injury. Gender in traumatic 
brain injury has been considered as a variable in many clinical and 
epidemiological studies but the findings have been equivocal, and 
often gender has not been specifically examined. But a study by 
Farace and Alves et al has found that women who have survived 
severe traumatic brain injury have poor outcomes. 
 Farin et al conducted a study in 2003  and has found that 
premenopausal females aged 50years and younger are more likely to 
have brain edema and intracranial hypertension than male patients 
with similar injury.  
 A much larger sample size is essential to assess the interaction 
between gender and prognosis of TBI thoroughly. 
GENETICS: 
 Genetic factors do play a role in predicting outcome after TBI.  
Waters RJ et al studied the genetic influences on outcome following 
acute neurological insults and found that the 14 allele of 
apolipoprotein E predisposes to poor outcome after TBI. 
MODE OF INJURY: 
 Penetrating head injuries have a worse outcome than blunt 
trauma. Patients with penetrating injuries usually present with a lower 
12 
 
GCS and tend to have a poorer outcome. Pedestrians and cyclists fare 
worse than occupants inside motor vehicles in an accident. 
PUPILLARY REFLEXES: 
 Various mechanisms associated with head injury can affect 
pupillary reflexes. It can be due to eye, optic, occulomotor nerve 
injury at any point in its course. If one excludes direct injury to the 
eye, then pupillary signs may provide prognostic information. 
 Haiden et al have found in their study that bilateral fixed pupils 
occur in about 20-30% of patients with severe head injury and about 
70-90% of these patients will have a bad outcome when compared 
with patients having severe head injury with bilaterally reactive pupils. 
Braakman R et al found in their study that non reactive pupils are 
generally associated with the presence of low GCS, hypotension, 
effaced basal cisterns on CT. 
 Phonprasert C et al studied that the underlying cause influences 
the prognostic value of unreactive pupils. Chesnut R et al in their 
study concluded that anisocoria is associated with an operable mass 
lesion in 30% of patients. 
GLASGOW COMA SCALE:  
 GCS is the widely used tool for assessment of consciousness, 
but it is not perfect and other methods do exist. Among the 3 
components of GCS eye opening and verbal responses are influenced 
13 
 
by swelling, local trauma and tracheal intubation. Marmarou A et al 
studied that the motor component of GCS is the most reliable factor in 
predicting the prognostic outcome in patients with moderate or severe 
head injury because the eye and verbal response is often absent in this 
patient. 
 Many studies have shown a relation between a low score on the 
GCS and a poor outcome. 
CT FINDINGS: 
 Abnormal finding on Computerized Tomographic study of brain 
(CT brain) increases with the severity of head injury. Marshall CT 
classification is the most widely used classification to standardize 
reporting of CT in TBI.  
 Haydel et al studied that patients with mild head injury have an 
abnormal CT rate of 2.5 to 8% whereas patients with moderate and 
severe head injury have an abnormal CT rate ranging from 50-94%. 
In the Brain Trauma Foundation guidelines, the status of basal 
cisterns, midline shift, presence and type of intracranial lesions and 
traumatic SAH have been identified to have important prognostic 
value. Effacement of the basal cisterns and the presence of SAH on 
CT are the strongest predictors of outcome. 
 It should be borne in mind that regardless of the CT 
classification used, other patient factors are important in determining 
14 
 
prognosis. The timing of the scan is important. CT is being performed 
earlier after traumatic brain injury due to better access to scanning 
facilities. This may result in missing operable lesions which develop 
later in the clinical course. Hence serial CT scans should be done in 
patients with TBI. 
HYPOTENSION: 
 An injured brain is more susceptible to systemic secondary 
insults like hypotension than normal brain. Secondary insults are 
common after traumatic injury of brain, and can increase the degree of 
damage and hence influence the outcome. Many studies have used a 
cut-oﬀ value for early hypotensive event (e.g., episode with a systolic 
blood pressure <90 mm Hg).  
 A detailed study of the association between the BP measured on 
admission and outcome showed that the relation is continuous i.e. low 
as well as high blood pressure are both associated with poorer 
outcome (U-shaped relation). 
 Chesnut RM et al studied the role of secondary brain injury in 
determining outcome from severe head injury in 1993 and found that 
even a single episode of hypotension in the period from injury to 






 Few observational studies in traumatic brain injury have found 
association between observed early hypoxia and poor outcome. 
[SpO2<90% or <7.9 kPa (60 mm Hg)]. 
But the association is not as strong as for hypotension. 
HYPERGLYCEMIA: 
 Hyperglycemia is quite common after brain injury. Many 
studies have concluded positive association between hyperglycemia, 
severity of injury and poor outcome for both early mortality and 
functional recovery in adults and children. 
 Peak levels greater than 200mg/dl in the first 24 hours after 
admission are associated with a significantly worse mortality and 
functional outcome up to 1 year post-injury. 
Prognostic models 
 Calculating prognosis involves multiple variables and it is a 
challenge. If we combine the individual variables into a prognostic 
model it will increase its performance in prognosticating the outcome. 
All these prognostic models should be externally validated which 
means that these models should be tested in a different setting that 





Prognostic scores available are as follows 
Madras Head Injury Prognostic Score (MHIPS) 
 This scoring system was devised by V.G.Ramesh et al
13
 in the 
year 2007.It was a prospective and retrospective study done at 
Institute of Neurology, Madras Medical College and Government 
General Hospital involving 459 patients. 
 
The various variables used were: 
1. Age 
2. Best Motor Response 
3. Pupillary Light Reflex 
4. Occulocephalic Reflex 
5. CT scan findings 
6. Systemic Injuries 
 Each variable is divided into three subgroups and a score is 
given based on prognosis. Maximum score is 18 and minimum score 
is 6. 
 Age was divided into 0-15years, 16-45years and >45 years. 
Pupillary light reflex and Occulocephalic reflexes were analyzed as 
impaired, absent or normal responses. CTfindings were analyzed as 
per Marshall’s CT classification. Other systemic injuries were also 
17 
 
taken into account. Maximum score in the subgroup was taken as 3 
and minimum as 1. 
NIMHANS model 
 This model was devised by S.V.Pillai et al in the year 2003 at 
NIMHANS Bangalore. It was a retrospective study done on 289 
patients
5
. The variables analyzed were 
1. Motor Score of GCS 
2. Occulocephalic Reflex 
3. CT Scan findings 
Occulocephalic reflex was scored as 1 and 2 in case of absent and 
present reflex respectively. 
Motor component of GCS was scored from 1to5 while midline shift 
was noted as CT scan finding and given score of 1,2,3 in case of 
absent ,<5mm,>5mm midline shift respectively. 
Outcome was predicted using the formula: 
 
 
 The patients with score of >/= 0 were considered to have 




3xOcculocephalic reflex +0.5 x Motor score of GCS-Midline shift-6.6 
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Edinburgh Prognostic Model: 
 This was devised by David F.Signorini et al at the University of 
Edinburgh, UK in the year 1997.It was a prospective study done on 
372 patients
12
. The variables analyzed were: 
1. Age 
2. GCS score 
3. Injury Severity Score 
4. Pupillary Reflex 
5. CT findings 
 The maximum possible score was 350 while minimum was 
0.The probability of survival was calculated using the normogram 
chart .The probability of survival was reported as .001 to 0.999. 
Narayan’s Logistic Model: 
 This was devised by Raj K Narayan et al in the year 1981 at 
Department of Neurosurgery, Virginia Medical College It was a 
prospective study conducted on 133 patients. The model included 
variables such as  
1. Age  
2. GCS score  
3. Pupillary reflexes  
4. Eye movements   
5. Motor response  
19 
 
6. Surgical mass lesions  
7.  CT scan findings   
8. Intracranial pressure measurement  
9. Multimodality evoked potentials  
Choi’s Model: 
 This model was described by Sung C.Choi et al in the year 1991 
at Virginia Medical College. It was a prospective study on 555 
patients. 
 It predicted the outcome after TBI based on age and unilateral 
or bilateral absent pupillary light reflexes.  
Leed’s Scoring System: 
 This scoring system was devised by R.Myles Gibson et al in the 
year 1983-1987.It was a retrospective study done on 187 patients .The 
variables used in this model were: 
1. Unreactive pupils 
2. ICP 
3. Systolic BP 
4. GCS Score 
5. High density lesion on CT scan 





Klauber’s Logistic Model: 
 This was described by Klauber M.R et al in the year 1980-81.at 
California University Medical Centre. It was a prospective study done 
on 7912 patients. It included variables like: 
1. Motor component of GCS 
2. Pupillary light reflex 
3. Systolic BP 
4. Age 
5. Chest Injury 
6. Abdominal Injury 
 
 The three scores MHIPS, NIMHANS Model, Edinburgh 
Prognostic score are simple, easy to apply on bedside to prognosticate 




















MATERIALS AND METHODS 
 This study was conducted at Madras Medical College and 
Rajiv Gandhi Government. General Hospital, Institute of 
Neurology which included 300 patients with moderate and severe 
traumatic brain injury. It was a prospective study from 2010 to 2013. 
 A thorough Clinical and detailed neurological examination was 
done and the patient details were recorded in a Proforma and the 
following Prognostic Scores were calculated for every patient: 
- Madras Head Injury Prognostic Scale (MHIPS). 
- NIMHANS Model (NM). 
- Edinburgh Prognostic Scale 
 The efficacy, sensitivity and specificity was noted for every 
score and compared for the outcome of these patients. 
 All Patients presenting to the trauma ward of our hospital with 
moderate and severe head injury along with other systemic injuries 
were included in our study population. 
 All patients presenting with mild head injury were excluded 
from our study population. 
 The primary reason for choosing to compare these three scores 




1. All the three scores have taken into account almost similar 
variables. 
2. All these scores are objective and measurable on a numerical 
scale. 
3. All the three scores are simple enough to be used during a 
routine bed side clinical assessment. 
4.  Also these scores are easy to apply even for a junior member of 
the team. 
The scoring system was calculated as per the following charts: 
MHIPS: 
1. Age :              a. 0-15 yrs  (3 points) 
      b.16-45yrs  (2points) 
      c. > 45yrs    (1 point) 
2. Best Motor Response : 
a. 1-2          (1 point) 
b. 3-4  (2 points) 
c. 5-6  (3 points) 
    3. Pupillary Light Reflex: 
a. Absent (1 point) 
b. Impaired  (2 points) 
c. Normal (3 points) 
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3.  Oculocephalic reflex : 
a. Absent   (1 point) 
b. Impaired   (2 points) 
c. Normal  (3 points) 
5. CT Findings: 




 (1 point) 




 (2 points) 
c. Normal basal cistern/no 
midline shift/no lesion






6.Systemic Injuries : 
a. Thoracic/abdominal/visc
eral injuries/>2long bone 
# (1point) 
b. One or two long bone #
 (2 points) 
c. No other systemic or 
long bone injuries  
 (3 points) 
 
NIMHANS Score: 
1. Oculocephalic Reflex : 
a. Absent   (1 point) 
b. Present  (2 points) 
2. Motor Score of GCS : 
a. 1   (1 point) 
b. 2   (2 points) 
c. 3   (3 points) 
d. 4   (4 points) 




3. Midline Shift Score :  
a. Absent  (1 point) 
b. <5mm  (2 points) 
c. >5mm  (3 points) 
 
Prediction Score = (3 x Oculocephalic reflex) + (0.5 x Best motor 
response) – (Midline shift)-6.6. 
Edinburgh Prognostic Score: 
1. Age : 
2. GCS Sum: 
3. Injury Severity Score : 
Region Injury description Abbreviated Injury Score Square top three 
Head and Neck    
Face    
Chest    
Abdomen    
Extremity    




4. Pupils :                            a. One Unreactive 
 b.Both Unreactive 
                                       c. Both Reactive 
   5. CT Scan                            a. No Hematoma 








Total Points = 






The 5 variables common to all the three studies were: 
1. Age 
2. Best Motor Response 
3. Pupillary Reflex  
4. Oculocephalic Reflex 
5. CT findings 
 As per the enclosed Proforma, the data from all 300 patients are 
collected.  
 
 Outcome is assessed for the same patients at 1 month interval. 
The collected data are arranged as per the enclosed master chart.  










RESULTS AND DISCUSSION 
1. Gender Distribution 
Out of 300 patients studied, 269(89.7%) patients were male while 
31(10.3%) patients were female. 
     Gender Distribution 
 
Total number of 
patients 
  
              300 
 
      100% 
 
           Male 
              
              269 
 
      89.7% 
 
          Female 
              
              31 
 
      10.3% 
Table 1 
 








Total number of 
patients 
Male Female 





 In this study, out of the total number of patients studied i.e. 300, 
there was a predominance of the male population i.e. 269 (89.7%) 
with traumatic brain injury than female population (10.3%). 
 A much larger sample size in essential to assess the interaction 
between gender and prognosis of TBI thoroughly.  
2. (A) Analysis of Age Distribution 
Age Group No. Of Patients Percentage 
0-15 years 12 4% 
16-45 years 198 66% 
>45 years 90 30% 
Table 2 
Age Distribution                                                                                            
 
Chart 2 
 Out of the 300 patients studied, the maximum numbers of 













(B) Age versus Outcome 





0 -15 years 4     (33.3%) 8      (66.7%) 12 
16-45 
years 
96   (48.5%) 102  (51.5%) 198 
>45years 57   (63.3%) 33    (36.7) 90 
( p value =.031)                          Table 3 
Age versus outcome 
        
 
Chart 3 
 On applying statistical analysis on age versus outcome in this 
study, 2/3
rd
 patients in age group 0-15years showed good outcome 
while 1/3
rd
 had unfavorable outcome.2/3
rd
 patients in the age group 
>45years had unfavourable outcome and only 1/3
rd









0 -15 years 16-45 years >45years 




 The patients admitted with TBI were mainly in the age group 
between 16 -45 years i.e.198 patients constituting 66% of the study 
population. The main cause of TBI was road traffic injury. 
 The outcome of TBI was seen to be worse with advancing age. 
Out of the 12 patients admitted in the age group of 0-15years, majority 
i.e.8 (66.7%) patients were seen to have good a good outcome at 
discharge. 
 While patients aged >45years were 90, out of which majority 
i.e. 57(66.3%) had an unfavorable outcome i.e. were either dead or 
had a poor outcome which included severe disability and persistent 
vegetative state based on Glasgow Outcome Scale. 
 Chantal W.P.M Hukkelhoven et al on a prospective study on 
5600 patients did an analysis about patient age and outcome following 
severe traumatic brain injury. The analysis revealed a mortality of 
21% and unfavourable outcome of 39% in patients less than 35years 
of age. The mortality was 52% and unfavourable outcome was 74% in 
patients older than 55 years. The study concluded that older age is 
constantly associated with a worsening outcome after TBI. 
 S.V Pillai et al in their retrospective study on 289 patients with 
severe traumatic brain injury found that 91% of patients with age 
>45years had unfavourable outcome while 71% of patients with age 
<45years had unfavourable outcome. 
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3. (A) Motor Response of GCS 
Analysis of Motor Response 
Best motor response Number of patients Percentage 
     1-2        69       23% 
     3-4        105       35% 
     5-6       126       42% 
Table 4 
 
Chart 4: Motor Response 
Motor response of study patients according to GCS scoring was 
analyzed. 
Out of the 300 patients studied, the maximum numbers of patients had 
best motor response of 5-6 i.e. 127(42.3%) patients, followed by 
104(34.7%) with best response between 3-4 and 69 (23%) patients 







     1-2      3-4      5-6 
     1-2 
     3-4 
     5-6 
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(B) Motor Response of GCS versus Outcome 
Best Motor 
Response 





1-2 67   (97.1%) 2      (2.9%) 69 
3-4 60   (57.1%) 45    (42.9%) 105 
5-6 30   (23.8%) 96    (76.2%) 126 
Total 157 143 300 
( p value =.000)                        Table 5 
 
 
Chart 5: Motor Response versus outcome 
 Our study included 126 patients with best motor response of 
GCS between 5-6. 
 96 (76.2%) patients had a favourable outcome at discharge (p 
value=.000). The number of patients with best motor response 








1 to 2 3 to 4 5 to 6 




outcome and score between 1-2 were 69 with 97.1% patients showed 
unfavourable outcome This showed that motor component of GCS is a 
reliable factor in predicting the prognostic outcome in patients with 
moderate and severe TBI. 
 The better the motor component of GCS on admission, the 
better the outcome.  
(p value =.000) 
 Raj K Narayan et al conducted a prospective study on 133 
patients on improved confidence of outcome prediction in severe head 
injury and found that patients with best motor response 1-2, 68% had 
unfavourable outcome and 32% had favourable outcome. Best motor 
response 3-4 59% patients had unfavourable outcome. Patients with 
best motor response 5-6, 96% of them had favourable outcome. 
 S.V.Pillai et al on their retrospective analysis of 289 patients on 
outcome model for severe traumatic brain injury had found that 
patients with best motor response on 1-2 had 96% unfavourable 
outcome and patients with best motor response 2-4 had 73% 







4. Pupillary Light Reflex: 
(A) Analysis of Pupillary Light reflex 
Pupillary Light 
Reflex 
Number of patients Percentage 
Absent 36 12% 
Impaired 72 24% 
Normal 192 64% 
Table 6 
Among the 300 patients, pupillary light reflex was normal in 
192(64%) patients whereas it was impaired in 72 patients (24%) and 
absent in 36 patients (12%). 
 
 








     Absent      Impaired      Normal 
     Absent 
     Impaired 
     Normal 
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Absent 29    (80.6%) 7     (19.4%) 36 
Impaired 67   (93.1%) 5      (6.9%) 72 
Normal 61   (31.8%) 131  (68.2%) 192 
Total 157 143 300 
  
(p value = .000)   Table 7 
 
Chart 7 
 The pupillary reflex was categorized as normal, impaired and 
absent. The majority of the patients with absent pupillary reflex i.e. 29 
out of 36 had an unfavourable outcome at discharge(80.6%).The 









Absent Impaired Normal 




to a good prognosis on discharge. 131 (68.2%) out of 192 patients 
with normal pupillary reflex had favourable outcome. 
 If one excludes direct injury to the eye, then pupillary signs 
provide prognostic information in moderate to severe TBI patients. 
 S.V.Pillai et al on their retrospective analysis of 289 patients 
found that among patients with absent pupillary light reflex, 96% had 
unfavourable outcome whereas patients in whom pupillary light reflex 
was present had only 60% unfavourable outcome. 
 Raj K Narayan et al on his prospective study on 133 patients 
showed that in patients with normal pupillary light reflex had 76% 
favourable outcome and 24% unfavorable outcome. In patients with 













5. Oculocephalic Reflex 
(A) Analysis of Oculocephalic Reflex 
Occulocephalic Reflex Number of patients Percentage 
Absent 18 6% 
Impaired 79 26.3% 





Evaluating Oculocephalic reflex, 203 patients showed normal reflex 
constituting 67.6% whereas it was impaired in 79 patients i.e. 26.3% 











     Absent      Impaired      Normal 
Analysis of Oculocephalic Reflex 
     Absent 
     Impaired 
     Normal 
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(B) Oculocephalic Reflex versus Outcome 
Occulocephalic 
Reflex 




   Total 
Absent           17    (94.4%)         1    (5.6%)       18 
Impaired           74   (93.7%)         5     (6.3%)       79 
Normal           66   (32.5%)         137(67.5%)       203 
Total           157         143       300 
 
(p value = .000)   Table 9 
 
Chart 9 
 Out of the 203 patients with normal pupillary response, 137 
patients i.e. 67.5% patients had favorable outcome on discharge, while 
out of the 18 patients admitted with absent pupillary response on 











Absent Impaired Normal 




 This showed a significant correlation between Oculocephalic 
reflex and outcome at discharge. (p value=.000). 
 S.V Pillai et al on their retrospective analysis of 289 patients 
found that in patients with absent Occulocephalic reflex, 98.4% had 
unfavourable outcome while patients with normal occucephalic 
reflexes 55% had unfavourable outcome. In our study 74 patients with 
impaired Oculocephalic reflex had unfavourable outcome. 
 50% of the study population had an unfavourable outcome with 
2/3
rd
















6. CT Scan Findings  
(A) Analysis of CT Findings 
CT Findings Number of patients Percentage 
Group 1 65 21.7% 
Group 2: 182 60.7% 
Group 3: 53 17.6% 
Table 10 
The study patients were grouped as follows based on CT findings: 
Group 1: Absent basal cisterns/midline shift >5mm/lesion density 
>3cm. 
Group 2: Partly effaced basal cisterns/midline shift <5mm/lesion 
density <3cm. 








     Group 1      Group 2:      Group 3: 
Analysis of CT findings 
     Group 1 
     Group 2: 
     Group 3: 
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 Out of 300 patients, normal CT findings were found in 53 i.e. 
(17.6%) patients. Group 1 constituted 65(21.7%) patients while group 
2 constituted the maximum i.e.182 patients (60.7%). 
 
(B) CT Scan findings versus Outcome 
CT 
findings 





Group 1 53    (81.5%) 12    (18.5%) 65 
Group 2 75   (41.2%) 107  (58.8%) 182 
Group 3 29   (54.7%) 24    (45.3%) 53 
Total 157 143 300 










Group 1 Group 2 Group 3 




 65 patients had group 1 CT findings on admission. Out of them 
53 (81.5%) patients were either dead or were having a poor outcome 
on discharge or at the end of 1 month. 
 The 182 patients showed group 2CT findings on admission. Out 
of them 107 (58.8%) patients had a good outcome on discharge or at 
the end of 1month. 
 53 patients CT scan findings were in group 3, out of which 29 
patients showed unfavourable outcome, while 24 patients showed 
favourable outcome. 
 CT scan analysis shows that even though normal CT scan is 
there, still unfavourable outcome happened in group 3. 
 The study showed that effacement of the basal cisterns and the 
presence of SAH on CT are good predictors of outcome in TBI 
patients. 
 As per Steven M. Toutant et al on a prospective study about 
absent or compressed basal cisterns on first CT scan: ominous 
predictors of outcome in severe head injury. The mortality rates were 
77% in patients with absent basal cistern, 39% with compressed basal 






                              
 
 
CT scan showing traumatic intra cerebral hemorrhage with lesion 
density >3cm 
 
    
                         
 
CT scan showing an acute right subdural hematoma with mass effect, 





7.Analysis of MHIPS Score 
 
(A)Analysis of MHIPS SCORE 
 
Score Number of patients Percentage 
</=12 62 20.7 % 
13-14 80 26.7% 






 Applying MHIPS score, 158 patients scored >/= 15 while 80 
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(B) MHIPS Score versus Outcome 
Outcome MHIPS Score Total 
 </=12 13-14 >/=15  
Dead 57   (92%) 33  (41.3%) 25   (15.8%) 115 
Poor 3     (4.8%) 31  (38.7%) 08   (5.1%) 42 
Good 2     (3.2%) 16  (20%) 125  
(79.1%) 
143 
Total 62 80 158 300 
Table 13 
Sensitivity = 0.87 
Specificity = 0.79 
Positive Predictive Value = 0.79 
Negative Predictive Value = 0.87 

















 Out of the 62 patients with MHIPS score </= 12, 57 patients i.e. 
92% patients were dead and 3 patients i.e.4.8% patients had poor 
outcome on discharge or at 1month after TBI. 
 Out of 80 patients with score of 13-14, 64 patients i.e. 80% of 
the patients had unfavourable outcome and only 20% patients had 
favourable outcome. 
 Out of the 158 patients admitted with MHIPS score of >/=15, 
125 patients i.e. 79.1% had good outcome and 11.9% had 
unfavourable outcome. 
 Therefore, a low MHIPS score was associated with 
unfavourable outcome and high MHIPS score was associated with 
favourable outcome in this study. This was consistent with the study 
conducted by V.G.Ramesh et al in 2007. 
 This scoring method has a good sensitivity of 87% and 
specificity of 79% for predicting the outcome in moderate and severe 
TBI. 









(A) Analysis of Edinburgh Model 
 
      Score Number of patients Percentage 
       <0.5        25       8.3% 
       >0.5        275       91.7% 




 The second score applied in this study was Edinburgh model 
where the scores were <0.5 and >0.5. 











       <0.5        >0.5 
       <0.5 
       >0.5 
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(B)Edinburgh Model versus Outcome 
            Outcome              Edinburgh Model Total 
      <0.5      >0.5  
Unfavourable (Poor+ Dead) 20(80%) 137(49.8%) 157 
Favourable (Good) 5(20%) 138(50.2%) 143 




Sensitivity =0.97    
Specificity = 0.13    
Positive Predictive Value=0.50 
Negative predictive Value=0.80    















 In this study, the number of patients admitted with a score of < 
0.5(probability of survival) were 25.Out of them 80% had 
unfavourable outcome and 20% had favourable outcome. 
 Out of the 275 patients admitted with score of >0.5,137 (49.8%) 
patients had unfavourable outcome and 138 (50.2%) patients had 
favourable outcome. 
 This scoring method predicted the poor outcome in patients 
with low scores; hence the sensitivity was high i.e.97%. 
 But in patients with score >0.5, the prediction was not as 
accurate hence the specificity was only 13%. 
 This study was conducted to see the outcome on discharge or at 
a period of 1month.In the original study the outcome was seen at the 
end of 1year.Hence this scoring method needs to be evaluated for a 
longer period of time and on a larger population study. 










9. NIMHANS Score  
(A) Analysis of NIMHANS Score 
      Score Number of patients Percentage 
       <0        242       81.4% 





 Applying NIMHANS score to the study population which has 













       <0        >0 
       <0 
       >0 
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(B) NIMHANS Score versus Outcome 
Outcome              NIMHANS Score Total 
      <0     >0  
Unfavourable (Poor+ Dead) 127 (52.5%) 30(51.7%) 157 
Favourable (Good) 115(47.5%) 28(48.3%) 143 
Total 242 58 300 
Table 17 
NIMHANS Score versus Outcome 
 
Chart 17 
Sensitivity = 0.20    
Specificity = 0.81    
Positive Predictive value=0.48      
Negative predictive value=0.52     














 Out of the 242 patients with score <0,127 i.e. 52.5% patients 
had unfavourable outcome while 115 patients i.e. 47.5% patients had 
favourable outcome. 
 Out of 58 patients admitted with score >0, 30 patients i.e. 51.7% 
had unfavourable outcome while 28 patients i.e. 48.3% had poor 
outcome. 
 This scoring system in this study did not predict satisfactorily 
the prognostic outcome in comparison to the actual outcome. The 
sensitivity of the scoring system was only 20% while specificity was 
81%.The p value is 0.517 which was not statistically significant. 
 Hence this scoring method needs to be evaluated with a larger 



























MHIPS .832 .025 .000 .783 .881 
NIMHANS .502 .033 .944 .437 .568 
Edinburgh .546 .033 .167 .481 .611 
 
Table 18 
 This shows that the maximum area under the curve is for 
MHIPS score i.e.0.832 followed by Edinburgh model i.e. 0.546 and 
least by NIMHANS score (0.502). 
 This proves MHIPS score to the best amongst all the three 
scores followed by Edinburgh Model. NIMHANS model as mentioned 













 In patients with moderate and severe head injury age of the 
patient plays a significant role in deciding the outcome. Older 
the patient poorer the prognosis. 
 In Glasgow Coma Scale, the best motor response is the most 
accurate predictor of outcome in moderate and severe head 
injury patients. 
 Both Occulocephalic and pupillary reflexes should be noted on 
admission in patients with moderate and severe TBI. Their 
response holds a significant correlation to the final outcome. 
 Single variable is not enough to prognosticate the outcome in 
traumatic brain injury patients. The scoring should always be a 
multivariate analysis 
 In this study Madras Head Injury prognostic Scale (MHIPS) 
was the most significant scoring system in accurate prediction 
of outcome in moderate and severe head injury patients as 
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TBI   – Traumatic Brain Injury 
MLS  – Midline shift 
EDH   – Extra dural hematoma 
SDH   – Sub dural hematoma 
BP   - Blood pressure  
SAH   – Sub arachnoid hemorrhage 
AIS   – Abbreviated injury Score 
ISS   – Injury Severity Score 
GCS   – Glasgow Coma Scale 
ICP   – Intracranial Pressure 
ER   – Emergency room 
GOS   – Glasgow Outcome Scale 
MHIPS  - Madras Head Injury Prognostic Scale 
NIMHANS - National Institute of Mental Health and Neurosciences 





Name:                                          IP No.                              DOA: 
Age                                               Sex    DOD: 
1. Age :                       a. 0-15 yrs 
      b.16-45 yrs 
      c. > 45yrs 
2. Best Motor Response:                            a.1-2 
                                                                    b.3-4 
                                                                    c.5-6 




4. Oculocephalic response: 
a. Absent  
b. Impaired  
c. Normal 
5.CT Scan Findings : 
a. Absent basal cistern/midline 
shift>5mm/lesion density>3cm 
diameter 
b. Partly effaced basal 
cistern/midline shift <5mm/lesion 
density<3cm diameter 
c. Normal basal cistern/no midline 
shift/no lesion 
6. Systemic Injuries: 
a. Thoracic/abdominal visceral 
injuries/>2long bone # 
b. One or two long bone # 





1.Oculocephalic Reflex : 
a. Absent  
b. Present 



































2. GCS Sum: 
3. ISS Score: 
Region Injury description AIS Square top three 
Head and Neck    
Face    
Chest    
Abdomen    
Extremity    
External    
1. Pupils :                                   a.One Unreactive 
                b.Both Unreactive 
                                         c. Both Reactive 
   5. CT Scan                              a. No Hematoma 






TOTAL POINTS = 
Probability of Survival = 
Sl.No Name Sex IP no. DOA DOD 0-15 16-45 >45 1 -- 2 3--4 5--6 Absent Impaired Normal Absent  impaired normal G1 >5>3 G2 <5<3 G3  normal >2 1 or 2 none Mhips Nimhans Edinburgh Dead Good Poor
1 Patient 1 M 60529 30/6/12 30/6/12 NO NO YES NO NO YES NO YES NO NO YES NO NO NO YES NO NO YES 14 0.9 0.99 YES NO NO
2 Patient 2 M 62493 15/7/12 23/7/12 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 17 0.9 0.99 NO YES NO
3 Patient 3 M 64814 07-12-2012 25/7/12 NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 16 0.9 0.99 NO YES NO
4 Patient 4 M 87401 07-03-2012 13/7/12 NO YES NO NO YES NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -0.6 0.95 NO YES NO
5 Patient 5 M 63074 07-08-2012 13/7/12 NO YES NO YES NO NO YES NO NO NO YES NO NO NO YES NO NO YES 12 0.6 0.74 YES NO NO
6 Patient 6 M 62081 05-12-2012 13/5/12 NO YES NO YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -0.6 0.94 YES NO NO
7 Patient 7 M 87702 07-07-2012 07-07-2012 NO YES NO YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -1.6 0.94 YES NO NO
8 Patient 8 M 14754 07-04-2012 08-01-2012 NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 16 0.4 0.99 NO NO YES
9 Patient 9 M 61552 07-03-2012 07-04-2012 NO NO YES NO YES NO NO NO YES NO NO YES YES NO NO NO NO YES 13 -1.6 0.6 YES NO NO
10 Patient 10 M 87606 20/6/12 22/6/12 NO YES NO YES NO NO YES NO NO YES NO NO YES NO NO NO NO YES 9 -6.1 0.75 YES NO NO
11 Patient 11 M 61304 14/7/12 18/7/12 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO 16 0.9 0.76 NO NO YES
12 Patient 12 F 55136 14/6/12 20/6/12 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 15 -0.1 0.98 NO YES NO
13 Patient 13 F 67954 22/7/12 28/7/12 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 15 -0.1 0.99 NO YES NO
14 Patient 14 M 66841 18/7/12 18/7/12 NO NO YES NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
15 Patient 15 M 65143 13/7/12 26/7/12 NO YES NO NO YES NO NO NO YES NO NO YES YES NO NO NO NO YES 14 -2.1 0.96 NO YES NO
16 Patient 16 F 55944 18/6/12 28/6/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.992 NO YES NO
17 Patient 17 M 53160 06-10-2012 21/6/12 NO NO YES NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -0.6 0.98 NO YES NO
18 Patient 18 F 60739 07-02-2012 17/7/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
19 Patient 19 M 66834 18/7/12 19/7/12 NO NO YES NO NO YES NO YES NO NO NO YES NO NO YES NO NO YES 15 0.9 0.96 YES NO NO
20 Patient 20 M 60725 07-02-2012 18/7/12 NO YES NO NO YES NO NO NO YES NO NO YES YES NO NO NO NO YES 14 -1.6 0.96 NO YES NO
21 Patient 21 M 79561 17/6/12 21/7/12 YES NO NO YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.6 0.97 NO NO YES
22 Patient 22 M 60634 07-08-2012 19/7/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
23 Patient 23 F 67777 21/7/12 28/7/12 NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 16 0.9 0.92 NO YES NO
24 Patient 24 M 44573 17/5/12 30/5/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.992 YES NO NO
25 Patient 25 M 91781 07-12-2012 13/7/12 NO NO YES YES NO NO YES NO NO YES NO NO YES NO NO NO NO YES 8 -6.1 0.3 YES NO NO
26 Patient 26 M 54769 14/6/12 15/6/12 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES YES NO NO 15 0.9 0.999 YES NO NO
27 Patient 27 M 87891 07-04-2012 25/7/12 NO YES NO NO NO YES NO YES NO NO YES NO YES NO NO NO NO YES 13 -1.1 0.96 NO YES NO
28 Patient 28 M 63619 07-09-2012 19/7/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.992 NO YES NO
29 Patient 29 M 67247 20/7/12 20/7/12 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 -0.6 0.96 YES NO NO
30 Patient 30 M 67258 20/7/12 27/7/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.99 NO YES NO
31 Patient 31 M 67279 19/7/12 25/7/12 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 17 0.9 0.995 NO YES NO
32 Patient 32 F 55133 07-12-2012 13/7/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 YES NO NO
33 Patient 33 M 57593 22/6/12 23/6/12 NO YES NO NO YES NO NO YES NO NO NO YES YES NO NO NO NO YES 13 -1.6 0.96 YES NO NO
34 Patient 34 M 66042 16/7/12 28/7/12 NO YES NO NO NO YES NO NO YES NO NO YES YES NO NO NO NO YES 15 -1.1 0.97 NO YES NO
35 Patient 35 M 79021 06-06-2012 14/7/12 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 15 -0.6 0.96 YES NO NO
36 Patient 36 M 49244 28/5/12 30/5/12 NO YES NO YES NO NO YES NO NO YES NO NO YES NO NO NO NO YES 9 -4.1 0.8 YES NO NO
37 Patient 37 M 57048 20/6/12 23/6/12 NO NO YES YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 11 -2.1 0.76 YES NO NO
38 Patient 38 F 64450 07-11-2012 13/7/12 NO NO YES NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -1.6 0.91 YES NO NO
39 Patient 39 M 57879 22/6/12 22/6/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.995 YES NO NO
40 Patient 40 F 58914 25/6/12 26/6/12 NO YES NO NO NO YES NO YES NO NO NO YES NO NO YES NO NO YES 16 0.9 0.97 YES NO NO
41 Patient 41 M 46774 21/5/12 22/5/12 NO YES NO YES NO NO YES NO NO NO YES NO NO YES NO NO YES NO 10 -1.6 0.75 YES NO NO
42 Patient 42 M 53897 06-11-2012 19/7/12 NO YES NO NO YES NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.1 0.99 NO NO YES
43 Patient 43 M 64812 07-12-2012 25/7/12 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 15 -0.1 0.95 NO YES NO
44 Patient 44 M 66453 23/7/12 23/7/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 YES NO NO
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45 Patient 45 F 63123 07-10-2012 15/7/12 YES NO NO NO YES NO NO YES NO NO NO YES YES NO NO NO NO YES 13 -1.6 0.96 YES NO NO
46 Patient 46 M 66461 23/7/12 08-01-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
47 Patient 47 M 62231 25/6/12 08-02-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO 16 0.9 0.76 NO NO YES
48 Patient 48 M 62254 25/6/12 30/7/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
49 Patient 49 M 53412 06-10-2012 06-10-2012 NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
50 Patient 50 M 65867 21/7/12 30/7/12 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 0.4 0.99 NO YES NO
51 Patient 51 M 65104 18/7/12 30/7/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 NO YES NO
52 Patient 52 M 58567 24/6/12 27/6/12 NO NO YES NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
53 Patient 53 M 64997 14/7/12 30/7/12 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
54 Patient 54 M 51342 31/5/12 06-02-2012 NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
55 Patient 55 M 68112 28/7/12 08-06-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
56 Patient 56 M 64763 16/7/12 18/7/12 NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
57 Patient 57 M 62297 25/6/12 08-04-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO 16 0.9 0.76 NO NO YES
58 Patient 58 M 61167 07-03-2012 08-04-2012 NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO 16 0.9 0.76 NO NO YES
59 Patient 59 F 69567 08-04-2012 08-05-2012 NO NO YES YES NO NO YES NO NO NO YES NO NO NO YES NO NO YES 12 0.6 0.74 YES NO NO
60 Patient 60 M 64776 16/7/12 20/7/12 NO YES NO YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -0.6 0.94 YES NO NO
61 Patient 61 M 71987 13/8/12 18/8/12 NO NO YES YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -1.6 0.94 YES NO NO
62 Patient 62 M 68912 30/7/12 08-11-2012 NO NO YES NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
63 Patient 63 F 69126 08-01-2012 16/8/12 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 17 0.9 0.99 NO YES NO
64 Patient 64 M 72234 14/8/12 20/8/12 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 16 0.9 0.99 NO YES NO
65 Patient 65 M 71587 08-11-2012 17/8/12 NO YES NO NO YES NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -0.6 0.95 NO YES NO
66 Patient 66 M 72254 14/8/12 18/8/12 NO NO YES NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
67 Patient 67 F 71345 08-08-2012 18/8/12 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 0.4 0.99 NO YES NO
68 Patient 68 M 70897 08-06-2012 14/8/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 NO YES NO
69 Patient 69 F 73456 20/8/12 21/8/12 YES NO NO YES NO NO YES NO NO NO YES NO NO NO YES NO NO YES 12 0.6 0.74 YES NO NO
70 Patient 70 M 69576 08-04-2012 08-10-2012 NO YES NO YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -0.6 0.94 YES NO NO
71 Patient 71 M 62887 07-08-2012 19/8/12 NO NO YES YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -1.6 0.94 YES NO NO
72 Patient 72 M 65987 22/7/12 08-09-2012 NO YES NO YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.6 0.97 NO NO YES
73 Patient 73 M 66098 23/7/12 08-09-2012 NO YES NO YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.6 0.97 NO NO YES
74 Patient 74 M 65998 22/7/12 08-09-2012 NO YES NO YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.6 0.97 NO NO YES
75 Patient 75 M 65873 21/7/12 08-08-2012 YES NO NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
76 Patient 76 M 62134 13/5/12 29/5/12 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO 16 0.9 0.76 NO NO YES
77 Patient 77 M 72386 16/8/12 18/8/12 NO YES NO YES NO NO YES NO NO NO YES NO NO NO YES NO NO YES 12 0.6 0.74 YES NO NO
78 Patient 78 M 72407 17/8/12 19/8/12 NO YES NO YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -0.6 0.94 YES NO NO
79 Patient 79 M 69503 08-03-2012 08-03-2012 NO YES NO YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -1.6 0.94 YES NO NO
80 Patient 80 M 71356 08-08-2012 15/8/12 NO YES NO YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.6 0.97 NO NO YES
81 Patient 81 M 70913 08-07-2012 13/8/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
82 Patient 82 M 68802 29/7/12 20/8/12 NO NO YES YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.6 0.97 NO NO YES
83 Patient 83 M 71402 08-09-2012 08-09-2012 NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
84 Patient 84 M 69135 08-01-2012 14/8/12 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 0.4 0.99 NO YES NO
85 Patient 85 M 70764 08-05-2012 14/8/12 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 NO YES NO
86 Patient 86 M 69145 08-01-2012 08-03-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 YES NO NO
87 Patient 87 M 75028 08-11-2012 08-12-2012 NO YES NO NO YES NO NO YES NO NO NO YES YES NO NO NO NO YES 13 -1.6 0.96 YES NO NO
88 Patient 88 F 74426 08-09-2012 20/8/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
89 Patient 89 M 67231 19/7/12 14/8/12 NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 13 0.4 0.96 NO NO YES
90 Patient 90 M 68812 21/7/12 08-07-2012 NO YES NO NO YES NO NO NO YES NO YES NO NO YES NO NO NO YES 13 -1.1 0.74 NO NO YES
91 Patient 91 M 67740 21/7/12 30/7/12 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 0.4 0.99 NO YES NO
92 Patient 92 M 69634 26/7/12 08-03-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 NO YES NO
93 Patient 93 M 82902 09-04-2012 09-05-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 YES NO NO
94 Patient 94 M 83650 09-05-2012 09-06-2012 NO NO YES NO YES NO NO YES NO NO NO YES YES NO NO NO NO YES 13 -1.6 0.96 YES NO NO
95 Patient 95 M 20088 17/8/12 31/8/12 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 0.4 0.99 NO YES NO
96 Patient 96 F 91473 27/9/12 10-07-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 NO YES NO
97 Patient 97 M 72363 08-04-2012 08-12-2012 NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
98 Patient 98 M 77337 18/8/12 25/8/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
99 Patient 99 M 79249 24/8/12 30/8/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 YES NO NO
100 Patient 100 M 82097 09-01-2012 09-06-2012 NO YES NO NO YES NO NO YES NO NO NO YES YES NO NO NO NO YES 13 -1.6 0.96 YES NO NO
101 Patient 101 M 11792 09-03-2012 09-11-2012 NO NO YES NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 13 0.4 0.96 NO NO YES
102 Patient 102 M 78240 21/8/12 09-10-2012 NO YES NO NO YES NO NO NO YES NO YES NO NO YES NO NO NO YES 13 -1.1 0.74 NO NO YES
103 Patient 103 M 79954 26/8/12 27/8/12 NO YES NO YES NO NO YES NO NO NO YES NO NO NO YES NO NO YES 12 0.6 0.74 YES NO NO
104 Patient 104 M 83247 09-04-2012 09-06-2012 NO NO YES YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -0.6 0.94 YES NO NO
105 Patient 105 M 88577 21/9/12 24/9/12 NO YES NO YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -1.6 0.94 YES NO NO
106 Patient 106 F 87335 17/9/12 20/9/12 NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
107 Patient 107 M 10274 28/7/12 08-11-2012 NO YES NO NO YES NO NO NO YES NO NO YES YES NO NO NO NO YES 14 -2.1 0.96 NO YES NO
108 Patient 108 M 74774 08-10-2012 20/8/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.992 NO YES NO
109 Patient 109 M 81528 30/8/12 09-11-2012 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -0.6 0.98 NO YES NO
110 Patient 110 F 81179 29/8/12 09-05-2012 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
111 Patient 111 M 88433 19/9/12 20/9/12 NO NO YES NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
112 Patient 112 M 76292 09-04-2012 15/9/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
113 Patient 113 M 81943 31/8/12 09-08-2012 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 YES NO NO
114 Patient 114 M 12634 14/9/12 20/9/12 NO NO YES NO YES NO NO YES NO NO NO YES YES NO NO NO NO YES 13 -1.6 0.96 YES NO NO
115 Patient 115 M 10410 08-06-2012 31/8/12 NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 13 0.4 0.96 NO NO YES
116 Patient 116 M 76708 08-11-2012 15/9/12 NO YES NO NO YES NO NO NO YES NO YES NO NO YES NO NO NO YES 13 -1.1 0.74 NO NO YES
117 Patient 117 M 10324 30/7/12 31/8/12 NO YES NO YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.6 0.97 NO NO YES
118 Patient 118 M 82435 09-03-2012 09-06-2012 NO YES NO YES NO NO YES NO NO NO YES NO NO NO YES NO NO YES 12 0.6 0.74 YES NO NO
119 Patient 119 M 87812 18/9/12 20/9/12 NO YES NO YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -0.6 0.94 YES NO NO
120 Patient 120 F 83747 09-06-2012 09-08-2012 NO YES NO YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -1.6 0.94 YES NO NO
121 Patient 121 M 84028 6/9/12/ 09-08-2012 NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
122 Patient 122 F 74742 08-10-2012 20/8/12 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
123 Patient 123 M 12073 09-09-2012 09-11-2012 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 YES NO NO
124 Patient 124 M 84714 09-09-2012 14/9/12 NO NO YES NO YES NO NO YES NO NO NO YES YES NO NO NO NO YES 13 -1.6 0.96 YES NO NO
125 Patient 125 M 101074 10-02-2012 10-03-2012 NO NO YES NO YES NO NO YES NO NO YES NO NO YES NO NO NO YES 12 -0.6 0.95 YES NO NO
126 Patient 126 M 102888 10-05-2012 25/10/12 NO YES NO NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES 16 0.4 0.6 NO NO YES
127 Patient 127 M 97775 25/9/12 10-01-2012 NO YES NO NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES 16 0.4 0.96 NO YES NO
128 Patient 128 M 99473 28/9/12 24/10/12 NO NO YES NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 13 0.4 0.96 NO NO YES
129 Patient 129 M 91618 14/8/12 10-03-2012 NO NO YES NO YES NO NO NO YES NO YES NO NO YES NO NO NO YES 13 -1.1 0.74 NO NO YES
130 Patient 130 M 99366 27/9/12 28/9/12 NO NO YES YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 11 -4.6 0.6 YES NO NO
131 Patient 131 M 99012 23/9/12 30/9/12 NO YES NO YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 12 -4.6 0.95 NO YES NO
132 Patient 132 M 99036 23/9/12 10-02-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 17 0.9 0.97 NO YES NO
133 Patient 133 M 99780 10-04-2012 10-11-2012 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 0.4 0.99 NO YES NO
134 Patient 134 M 96319 08-12-2012 20/8/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 NO YES NO
135 Patient 135 M 101092 10-03-2012 10-10-2012 NO NO YES NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.6 0.6 NO YES NO
136 Patient 136 M 101209 10-03-2012 10-12-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
137 Patient 137 M 101529 10-04-2012 10-11-2012 NO NO YES NO NO YES YES NO NO NO NO YES NO YES NO NO NO YES 15 -0.1 0.94 NO YES NO
138 Patient 138 M 101556 10-04-2012 10-09-2012 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 15 -0.1 0.96 NO YES NO
139 Patient 139 M 101153 10-02-2012 10-03-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO YES NO 15 -0.1 0.94 YES NO NO
140 Patient 140 F 99576 29/9/12 29/9/12 NO NO YES NO YES NO NO NO YES NO NO YES YES NO NO NO NO YES 13 0.4 0.94 YES NO NO
141 Patient 141 M 110173 10-07-2012 10-07-2012 NO YES NO YES NO NO YES NO NO YES NO NO NO NO YES NO NO YES 11 -3.6 0.97 YES NO NO
142 Patient 142 M 110692 10-09-2012 10-09-2012 NO NO YES YES NO NO NO YES NO NO YES NO YES NO NO NO NO YES 10 -0.6 0.9 YES NO NO
143 Patient 143 M 99812 25/9/12 25/9/2012 NO NO YES NO YES NO YES NO NO NO YES NO NO YES NO NO NO YES 11 -3.6 0.5 YES NO NO
144 Patient 144 M 86314 14/9/12 15/9/2012 NO YES NO YES NO NO YES NO NO YES NO NO NO YES NO NO NO YES 10 -4.6 0.86 YES NO NO
145 Patient 145 M 70937 08-08-2012 09-10-2012 NO YES NO NO YES NO NO YES NO NO NO YES NO NO YES NO NO YES 15 -0.6 0.97 NO NO YES
146 Patient 146 F 81193 06-03-2012 07-10-2012 NO NO YES NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -4.6 0.73 NO NO YES
147 Patient 147 M 94681 17/8/12 23/8/12 NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES YES NO NO 14 0.9 0.95 NO YES NO
148 Patient 148 M 107961 10-12-2012 19/10/12 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 17 0.9 0.993 NO YES NO
149 Patient 149 M 98121 22/9/12 14/10/12 NO NO YES NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 13 -1.6 0.8 NO NO YES
150 Patient 150 M 88614 08-01-2012 08-09-2012 NO NO YES NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES 15 0.4 0.9 NO YES NO
151 Patient 151 M 76312 06-12-2012 14/7/12 NO YES NO NO YES NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -0.6 0.95 NO NO YES
152 Patient 152 M 88102 20/9/12 27/9/12 YES NO NO NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO 17 0.4 0.99 NO YES NO
153 Patient 153 M 74312 25/6/12 26/6/12 NO YES NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES NO 13 -0.6 0.96 YES NO NO
154 Patient 154 M 96432 14/9/12 10-04-2012 NO NO YES NO YES NO NO YES NO NO YES NO NO YES NO NO NO YES 12 -0.6 0.25 NO NO YES
155 Patient 155 M 88606 17/09/12 23/09/12 NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 16 -0.1 0.5 NO YES NO
156 Patient 156 M 88354 16/09/12 23/09/12 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 17 -0.1 0.99 NO YES NO
157 Patient 157 M 16432 22/6/12 29/6/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.98 NO YES NO
158 Patient 158 M 99201 27/9/12 10-03-2012 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.99 NO YES NO
159 Patient 159 M 88214 24/8/12 29/8/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 15 -0.6 0.9 NO YES NO
160 Patient 160 M 76314 07-12-2012 19/7/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.98 NO YES NO
161 Patient 161 M 74132 13/6/12 07-10-2012 NO NO YES NO YES NO NO YES NO NO NO YES YES NO NO NO NO YES 12 -2.1 0.95 NO NO YES
162 Patient 162 M 99543 23/9/12 30/9/12 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 15 -0.1 0.75 NO YES NO
163 Patient 163 M 88321 21/9/12 22/9/12 NO NO YES NO YES NO NO NO YES NO NO YES YES NO NO NO NO YES 13 -2.5 0.75 YES NO NO
164 Patient 164 M 88654 20/9/12 29/9/12 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO 16 -0.1 0.99 NO YES NO
165 Patient 165 M 99353 24/9/12 30/9/12 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 15 -0.1 0.96 NO YES NO
166 Patient 166 M 10154 06-12-2012 18/6/12 NO YES NO NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES 16 -1.6 0.95 NO YES NO
167 Patient 167 M 10165 06-12-2012 06-12-2012 NO YES NO NO NO YES NO NO YES NO NO YES YES NO NO NO NO YES 15 -1.1 0.95 YES NO NO
168 Patient 168 M 99875 24/9/12 19/10/2012 NO YES NO YES NO NO YES NO NO NO YES NO YES NO NO NO NO YES 10 -2 0.76 NO NO YES
169 Patient 169 M 88462 30/7/12 30/7/12 NO NO YES NO YES NO NO NO YES NO YES NO NO YES NO NO NO YES 13 -2.1 0.75 YES NO NO
170 Patient 170 M 76492 06-05-2012 06-06-2012 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 -2.1 0.9 YES NO NO
171 Patient 171 M 99467 25/9/12 10-01-2012 NO YES NO YES NO NO YES NO NO YES NO NO YES NO NO NO NO YES 7 -6.1 0.75 NO YES NO
172 Patient 172 M 88671 08-01-2012 08-08-2012 NO YES NO NO NO YES NO NO YES NO NO YES YES NO NO NO NO YES 15 -1.1 0.95 NO YES NO
173 Patient 173 M 10147 06-02-2012 06-12-2012 YES NO NO NO NO YES NO YES NO NO NO YES NO YES NO NO NO YES 16 -0.1 0.99 NO YES NO
174 Patient 174 M 96302 15/9/12 10-12-2012 NO NO YES YES NO NO NO YES NO NO YES NO YES NO NO NO NO YES 12 -4.6 0.95 YES NO NO
175 Patient 175 M 97021 13/10/12 15/10/12 NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
176 Patient 176 M 94082 10-05-2012 16/10/12 NO YES NO NO YES NO NO NO YES NO NO YES YES NO NO NO NO YES 14 -2.1 0.96 NO YES NO
177 Patient 177 M 12813 24/9/12 29/9/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.992 NO YES NO
178 Patient 178 F 91517 28/9/12 10-09-2012 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -0.6 0.98 NO YES NO
179 Patient 179 M 96805 10-12-2012 18/10/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
180 Patient 180 F 82166 09-01-2012 09-12-2012 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
181 Patient 181 M 94620 10-07-2012 10-08-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 YES NO NO
182 Patient 182 M 89622 23/9/12 10-08-2012 NO YES NO NO YES NO NO YES NO NO NO YES YES NO NO NO NO YES 13 -1.6 0.96 YES NO NO
183 Patient 183 M 88647 20/9/12 24/9/12 YES NO NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
184 Patient 184 M 79170 23/8/12 09-08-2012 NO NO YES YES NO NO YES NO NO YES NO NO NO NO YES NO NO YES 11 -3.6 0.97 YES NO NO
185 Patient 185 M 79197 23/8/12 29/8/12 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO YES NO 15 -0.1 0.94 YES NO NO
186 Patient 186 M 79595 25/8/12 09-01-2012 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 0.4 0.99 NO YES NO
187 Patient 187 M 77577 20/8/12 09-06-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 NO YES NO
188 Patient 188 M 89562 23/9/12 10-01-2012 NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
189 Patient 189 M 74308 08-11-2012 22/8/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
190 Patient 190 M 81881 31/8/12 09-01-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO YES NO 15 -0.1 0.94 YES NO NO
191 Patient 191 M 74762 10/8/12/ 08-12-2012 NO NO YES NO YES NO NO NO YES NO NO YES YES NO NO NO NO YES 13 0.4 0.94 YES NO NO
192 Patient 192 M 84748 09-09-2012 18/9/12 NO YES NO YES NO NO YES NO NO YES NO NO NO NO YES NO NO YES 11 -3.6 0.97 YES NO NO
193 Patient 193 M 89596 23/9/12 26/9/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO YES NO 15 -0.1 0.94 YES NO NO
194 Patient 194 M 93403 10-03-2012 10-08-2012 NO YES NO NO YES NO NO NO YES NO NO YES YES NO NO NO NO YES 13 0.4 0.94 YES NO NO
195 Patient 195 M 88366 19/9/12 25/9/12 NO NO YES YES NO NO YES NO NO YES NO NO NO NO YES NO NO YES 11 -3.6 0.97 YES NO NO
196 Patient 196 M 81151 29/8/12 24/9/12 NO YES NO YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.6 0.97 NO NO YES
197 Patient 197 M 85771 09-12-2012 25/9/12 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 0.4 0.99 NO YES NO
198 Patient 198 M 85951 12/9/12/ 24/9/12 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 NO YES NO
199 Patient 199 M 86024 09-12-2012 25/9/12 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.6 0.6 NO YES NO
200 Patient 200 M 93439 10-04-2012 17/10/12 YES NO NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.6 0.6 NO YES NO
201 Patient 201 M 88334 19/9/12 25/9/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
202 Patient 202 M 95878 10-10-2012 16/10/12 NO YES NO NO NO YES YES NO NO NO NO YES NO YES NO NO NO YES 15 -0.1 0.94 NO YES NO
203 Patient 203 M 91052 26/9/12 10-01-2012 NO YES NO NO NO YES YES NO NO NO NO YES NO YES NO NO NO YES 15 -0.1 0.94 NO YES NO
204 Patient 204 M 85201 09-10-2012 13/9/12 NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
205 Patient 205 M 92237 30/9/12 10-04-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
206 Patient 206 M 92699 10-01-2012 10-04-2012 NO NO YES NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 13 0.4 0.96 NO NO YES
207 Patient 207 M 77843 20/8/12 10-08-2012 NO YES NO NO YES NO NO NO YES NO YES NO NO YES NO NO NO YES 13 -1.1 0.74 NO NO YES
208 Patient 208 F 84312 27/8/12 09-04-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
209 Patient 209 M 77567 20/8/12 22/8/12 NO NO YES NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
210 Patient 210 M 81071 28/8/12 21/9/12 NO YES NO YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.6 0.97 NO NO YES
211 Patient 211 M 83205 09-04-2012 09-10-2012 NO NO YES NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 0.4 0.99 NO YES NO
212 Patient 212 F 78302 21/8/12 09-04-2012 NO YES YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 NO YES NO
213 Patient 213 F 83232 09-04-2012 14/9/12 NO YES NO YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.6 0.97 NO NO YES
214 Patient 214 M 76390 16/8/12 23/8/12 NO NO YES NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 0.4 0.99 NO YES NO
215 Patient 215 M 84832 09-10-2012 10-06-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 NO YES NO
216 Patient 216 M 81151 29/8/12 09-08-2012 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.6 0.6 NO YES NO
217 Patient 217 M 77279 18/8/12 25/8/12 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 0.4 0.99 NO YES NO
218 Patient 218 M 83883 09-06-2012 09-11-2012 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 NO YES NO
219 Patient 219 M 89393 22/9/12 24/9/12 NO NO YES NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -4.6 0.5 YES NO NO
220 Patient 220 M 74523 08-10-2012 25/8/12 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 0.4 0.99 NO YES NO
221 Patient 221 M 79818 25/8/12 09-07-2012 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 NO YES NO
222 Patient 222 M 84005 09-06-2012 09-08-2012 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.6 0.6 NO YES NO
223 Patient 223 M 98069 16/10/12 17/10/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO YES NO 15 -0.1 0.94 YES NO NO
224 Patient 224 M 94538 10-07-2012 14/10/12 NO YES NO NO YES NO NO NO YES NO NO YES YES NO NO NO NO YES 13 0.4 0.94 YES NO NO
225 Patient 225 M 90620 25/9/12 29/9/12 NO NO YES YES NO NO YES NO NO YES NO NO NO NO YES NO NO YES 11 -3.6 0.97 YES NO NO
226 Patient 226 M 86357 13/9/12 18/9/12 YES NO NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.6 0.6 NO YES NO
227 Patient 227 M 78810 23/8/12 25/8/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
228 Patient 228 M 92067 29/9/12 10-04-2012 NO NO YES NO NO YES YES NO NO NO NO YES NO YES NO NO NO YES 15 -0.1 0.94 NO YES NO
229 Patient 229 F 86385 13/9/12 13/9/12 NO NO YES YES NO NO YES NO NO YES NO NO NO NO YES NO NO YES 11 -3.6 0.97 YES NO NO
230 Patient 230 M 83921 09-06-2012 09-06-2012 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO YES NO 15 -0.1 0.94 YES NO NO
231 Patient 231 M 82230 09-01-2012 14/9/12 NO NO YES NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.6 0.6 NO YES NO
232 Patient 232 M 77535 19/8/12 15/9/12 NO NO YES YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.6 0.97 NO NO YES
233 Patient 233 M 86808 14/9/12 21/9/12 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.6 0.6 NO YES NO
234 Patient 234 M 79562 24/8/12 20/9/12 NO NO YES YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.6 0.97 NO NO YES
235 Patient 235 M 74814 08-11-2012 22/8/12 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.6 0.6 NO YES NO
236 Patient 236 M 76835 17/8/12 27/8/12 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
237 Patient 237 M 88869 09-01-2012 23/9/12 NO NO YES YES NO NO YES NO NO YES NO NO NO NO YES NO NO YES 11 -3.6 0.97 YES NO NO
238 Patient 238 M 89634 23/9/12 23/9/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO YES NO 15 -0.1 0.94 YES NO NO
239 Patient 239 F 90246 24/9/12 10-01-2012 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.6 0.6 NO YES NO
240 Patient 240 M 87772 17/9/12 10-02-2012 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
241 Patient 241 M 13691 15/10/12 18/10/12 NO NO YES NO NO YES YES NO NO NO NO YES NO YES NO NO NO YES 15 -0.1 0.94 NO YES NO
242 Patient 242 M 92285 10-01-2012 10-06-2012 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
243 Patient 243 M 91828 28/9/12 10-06-2012 NO NO YES YES NO NO YES NO NO YES NO NO NO NO YES NO NO YES 11 -3.6 0.97 YES NO NO
244 Patient 244 M 77889 20/8/12 25/8/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO YES NO 15 -0.1 0.94 YES NO NO
245 Patient 245 M 94657 10-07-2012 18/10/12 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.6 0.6 NO YES NO
246 Patient 246 M 824333 09-03-2012 20/9/12 NO YES NO YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.6 0.97 NO NO YES
247 Patient 247 M 88084 18/9/12 21/9/12 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.6 0.6 NO YES NO
248 Patient 248 M 86534 14/9/12 21/9/12 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.97 NO YES NO
249 Patient 249 M 92965 2/10/12/ 14/10/12 NO YES NO NO NO YES YES NO NO NO NO YES NO YES NO NO NO YES 15 -0.1 0.94 NO YES NO
250 Patient 250 M 16391 12-10-2012 01-01-2013 NO NO YES YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.6 0.97 NO NO YES
251 Patient 251 M 121924 24/12/12 01-04-2013 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 0.4 0.99 NO YES NO
252 Patient 252 M 121965 24/12/12 01-04-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 NO YES NO
253 Patient 253 M 122010 25/12/12 01-04-2013 NO YES NO NO YES NO NO NO YES NO NO YES YES NO NO NO NO YES 14 -2.1 0.96 NO YES NO
254 Patient 254 M 92 01-01-2013 01-07-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.992 NO YES NO
255 Patient 255 M 122587 26/12/12 01-02-2013 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 0.4 0.99 NO YES NO
256 Patient 256 M 125975 25/12/12 01-02-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 NO YES NO
257 Patient 257 M 122579 26/12/12 01-07-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 17 -0.1 0.99 NO YES NO
258 Patient 258 F 120531 20/12/12 01-07-2013 NO YES NO YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 13 -1.6 0.97 NO NO YES
259 Patient 259 M 635 01-03-2013 01-05-2013 NO YES NO YES NO NO YES NO NO YES NO NO YES NO NO NO NO YES 9 -4.1 0.8 YES NO NO
260 Patient 260 M 578 01-02-2013 01-05-2013 NO YES NO YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 11 -4.6 0.6 YES NO NO
261 Patient 261 M 123644 30/12/12 01-03-2013 NO YES NO NO YES NO NO NO YES NO NO YES YES NO NO NO NO YES 14 -2.1 0.96 NO YES NO
262 Patient 262 F 118500 13/12/12 01-02-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.992 NO YES NO
263 Patient 263 M 123387 30/12/12 01-03-2013 NO NO YES YES NO NO YES NO NO NO YES NO NO NO YES NO NO YES 12 0.6 0.74 YES NO NO
264 Patient 264 M 1083 4/1/13` 01-06-2013 NO YES NO YES NO NO YES NO NO YES NO NO YES NO NO NO NO YES 9 -4.1 0.8 YES NO NO
265 Patient 265 M 123000 28/12/12 01-03-2013 NO YES NO NO YES NO NO NO YES NO NO YES NO YES NO NO NO YES 15 0.4 0.99 NO YES NO
266 Patient 266 M 122804 27/12/12 01-04-2013 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.96 NO YES NO
267 Patient 267 M 16696 14/12/12 01-01-2013 NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 13 0.4 0.96 NO NO YES
268 Patient 268 M 12327 28/12/12 01-07-2013 NO YES NO NO YES NO NO NO YES NO YES NO NO YES NO NO NO YES 13 -1.1 0.74 NO NO YES
269 Patient 269 M 1116654 12-08-2012 01-02-2013 NO YES NO YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 11 -4.6 0.6 YES NO NO
270 Patient 270 M 315 01-05-2013 01-07-2013 NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 13 0.4 0.96 NO YES NO
271 Patient 271 M 169 01-05-2013 01-07-2013 NO YES NO NO YES NO NO NO YES NO YES NO NO YES NO NO NO YES 13 -1.1 0.74 NO YES NO
272 Patient 272 M 1472 01-05-2013 01-07-2013 NO YES NO YES NO NO YES NO NO NO YES NO NO NO YES NO NO YES 12 0.6 0.74 YES NO NO
273 Patient 273 M 123475 29/12/12 01-01-2013 NO YES NO YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -0.6 0.94 YES NO NO
274 Patient 274 M 123682 31/12/12 01-05-2013 NO YES NO YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -1.6 0.94 YES NO NO
275 Patient 275 M 124037 31/12/12 01-08-2013 NO NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.98 NO YES NO
276 Patient 276 M 123922 31/12/12 01-08-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.99 NO YES NO
277 Patient 277 M 121940 24/12/12 01-05-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 15 -0.6 0.9 NO YES NO
278 Patient 278 M 4 01-01-2013 01-10-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 16 -0.1 0.5 NO YES NO
279 Patient 279 M 2211 07-01-2013 01-09-2013 NO YES NO YES NO NO YES NO NO YES NO NO YES NO NO NO NO YES 9 -4.1 0.8 YES NO NO
280 Patient 280 M 2030 07-01-2013 01-08-2013 NO YES NO YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 11 -2.1 0.76 YES NO NO
281 Patient 281 M 1667 06-01-2013 01-08-2013 NO YES NO NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -1.6 0.91 YES NO NO
282 Patient 282 M 185 01-01-2013 01-11-2013 YES NO NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 16 -0.1 0.5 NO YES NO
283 Patient 283 M 3919 13/1/13 14/1/13 NO YES NO YES NO NO YES NO NO NO YES NO NO NO YES NO NO YES 12 0.6 0.74 YES NO NO
284 Patient 284 M 2590 09-01-2013 01-11-2013 NO YES NO YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -0.6 0.94 YES NO NO
285 Patient 285 M 309 01-08-2013 01-12-2013 NO NO YES YES NO NO NO NO YES NO NO YES NO YES NO NO NO YES 14 -1.6 0.94 YES NO NO
286 Patient 286 M 122582 26/12/12 01-08-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 17 -0.1 0.99 NO YES NO
287 Patient 287 M 610 01-02-2013 01-08-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.98 NO YES NO
288 Patient 288 M 3020 01-10-2013 01-10-2013 YES NO NO YES NO NO YES NO NO YES NO NO YES NO NO NO NO YES 9 -4.1 0.8 YES NO NO
289 Patient 289 M 2925 01-09-2013 01-11-2013 NO YES NO YES NO NO NO YES NO NO YES NO NO YES NO NO NO YES 11 -2.1 0.76 YES NO NO
290 Patient 290 M 2918 01-09-2013 01-09-2013 NO NO YES NO YES NO NO YES NO NO YES NO YES NO NO NO NO YES 11 -1.6 0.91 YES NO NO
291 Patient 291 F 1013 01-03-2013 01-07-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 16 -0.1 0.5 NO YES NO
292 Patient 292 M 677 01-03-2013 01-07-2013 YES NO NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 17 -0.1 0.99 NO YES NO
293 Patient 293 M 978 01-03-2013 01-09-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.98 NO YES NO
294 Patient 294 M 970 01-03-2013 01-09-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.99 NO YES NO
295 Patient 295 M 1063 01-04-2013 01-09-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 15 -0.6 0.9 NO YES NO
296 Patient 296 M 123537 30/12/12 01-09-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 16 -0.1 0.5 NO YES NO
297 Patient 297 M 123608 30/12/12 01-09-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 17 -0.1 0.99 NO YES NO
298 Patient 298 M 123637 30/12/12 01-10-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO YES NO NO NO YES 16 -0.1 0.98 NO YES NO
299 Patient 299 M 1074 01-04-2013 01-07-2013 NO YES NO YES NO NO YES NO NO YES NO NO YES NO NO NO NO YES 9 -4.1 0.8 YES NO NO
300 Patient 300 M 3061 01.12.12 02-01-2013 NO YES NO NO NO YES NO NO YES NO NO YES NO NO YES NO NO YES 16 -0.1 0.5 NO YES NO
Note :- G1 = Group 1, G2 = Group 2, G3 = Group 3
                               INFORMATION SHEET 
We are conducting ‘“Comparison of various head injury prognostic 
scales” among patients attending Rajiv Gandhi Government General 
Hospital, Chennai and for that your specimen may be valuable to us. 
 
 
The purpose of this study is to  
a. Apply various prognostic scales on the outcome of moderate and    
   severe head injury patients. 
b Assessment of the efficacy of the prognostic score 
c. To recognize the sensitivity and specificity of the various prognostic scales 
 
We are selecting certain cases and if your radiological image is found eligible, 
we may be using your specimen to perform extra tests and special studies 
which in any way do not affect your final report or management. 
 The privacy of the patients in the research will be maintained 
throughout the study. In the event of any publication or presentation 
resulting from the research, no personally identifiable information will 
be shared. 
 Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will 
not result in any loss of benefits to which you are otherwise entitled. 
 The results of the special study may be intimated to you at the end of 
the study period or during the study if anything is found abnormal 








ஆராய்ச்சி தகவல் தாள் 
 
 
 தங்களின் சிடி ஸ்ககன் / எம்.ஆர்.ஐ ஸ்ககன் படம் அல்லது 
படத்தின் நகல் அல்லது படத்தின் நிழல்படம் இங்கு 
பபறப்பட்டுள்ளது 
 ராஜீவ் காந்தி அரசு மருத்துவக்கல்லூாி  மற்றும்  அரசு பபாது 
மருத்துவமனையின் நரம்பியல் அறுனவ சிகிச்னசத் துனறயில் " 
தலையில் காயம் பல்வேறு முன்கணிப்பு செதில்கள் ஒப்படீு” 
பற்றிய ஆய்வு நனடபபறுகிறது 
 சிடி ஸ்ககன், மற்றும் எம்.ஆர்.ஐ ஸ்ககன் ஆகியவற்றின் 
அடிப்பனடயில் இந்த ஆய்வு நனடபபறுகிறது 
 இவ்வாய்வில் கலந்து பகாள்பவர்களின் பசாந்த தகவல்கள் 
ரகசியமாக பாதுக்காகபடும் 
 இந்த ஆய்வின் முடிவுகனள பிரசுாிக்குகபாது அல்லது 
பவளியிடும்கபாகதா தங்களின் பசாந்த தகவல்கள் ஏதும் 
பவளியிடபடாது 
 இந்த ஆய்வில் பங்குபபற அல்லது விலகிக்பகாள்ள உங்களுக்கு 
முழு சுதந்திரம் உண்டு 
 இந்த ஆய்வில் இருந்து நீங்கள் விலகிபகாண்டாலும் 




ஆராய்ச்சியாளர் னகபயாப்பம்பங்ககற்பாளர் னகபயாப்பம் 
 
நாள் 
ஆராய்ச்சி ஒப்புதல் கடிதம் 
ஆராய்ச்சி தனலப்பு :  
பபயர் : வயது/பால் :   கததி : 
ஆராய்ச்சி கசர்க்னக எண் : 
 ராஜீவ் காந்தி அரசு மருத்துவக்கல்லூாி  மற்றும்  அரசு பபாது 
மருத்துவமனையின் நரம்பியல் அறுனவ சிகிச்னசத் துனறயில்     
"தலையில் காயம் பல்வேறு முன்கணிப்பு செதில்கள் ஒப்படீு” 
பற்றிய ஆய்வு நனடபபறுகிறது என்பனத அறிந்து பகாண்கடன் 
 சிடி ஸ்ககன், மற்றும் எம்.ஆர்.ஐ ஸ்ககன் ஆகியவற்றின் 
அடிப்பனடயில் இந்த ஆய்வு நனடபபறுகிறது என்பனதயும் கமலும் 
அறுனவ சிகிச்னசயின் கபாது கநரடியாக பார்க்கப்படுவனத 
னவத்தும் ஆய்வு நனடபபறுகிறது என்பனதயும் அறிந்து 
பகாண்கடன் 
 இவ்வாய்வில் கலந்து பகாள்பவர்களின் பசாந்த தகவல்கள் 
ரகசியமாக பாதுக்காகபடும் என்பனதயும் இந்த ஆய்வின் 
முடிவுகனள பிரசுாிக்குகபாது அல்லது பவளியிடும்கபாகதா 
தங்களின் எைது தகவல்கள் ஏதும் பவளியிடபடாது என்பனதயும் 
அறிந்து பகாண்கடன் 
 இந்த ஆராய்ச்சியிலிருந்து எந்த கநரமும் பின் வாங்கலாம் என்றும், 
அதைால் எந்த பாதிப்பும் எற்படாது என்பனதயும் அறிந்து 
பகாண்கடன் 
 இந்த ஆய்வில் பங்குபபற அல்லது விலகிக்பகாள்ள எைக்கு முழு 
சுதந்திரம் உண்டு என்பனதயும், இந்த ஆய்வில் இருந்து நான் 
விலகிபகாண்டாலும் எைக்கு கினடக்ககவண்டிய சிகிச்னச 
பதாடர்ந்து கினடக்கும் என்பனதயும் அறிந்து பகாண்கடன் 
 இந்த ஆராய்ச்சியின் விவரங்களும், அதன் கநாக்கங்களும் எைக்கு 
பதளிவாக விளக்கப்பட்டது. எைக்கு விளக்கப்பட்ட விவரங்கனள 
புாிந்து பகாண்டு, இந்த ஆய்வில் கலந்து பகாள்ள சம்மதிக்கிகறன் 
 இந்த ஆராய்ச்சியில் பிறாின் நிர்பந்தமின்றி என் பசாந்த 




INFORMED CONSENT FORM 
 
Title of the study :“‘“ Comparison of various head injury 
prognostic scales”” 
Name of the Participant: Dr. Goutham S P 
Name of the Principal (Co-Investigator): Prof. K. Deiveegan, M.S., M.Ch., 
Name of the Institution: Institute of Neurology, MadrasMedicalCollege and 
RajivGandhiGovernment GeneralHospital, Chennai 
Name and address of the sponsor / agency (ies) (if any): None. 
Documentation of the informed consent 
I _____________________________ have read the information in this form 
(or it has been read to me). I was free to ask any questions and they have been 
answered. I am over 18 years of age and, exercising my free power of choice, 
hereby give my consent to be included as a participant in “Comparison of 
various head injury prognostic scales” 
1. I have read and understood this consent form and the information provided 
to me. 
2. I have had the consent document explained to me. 
3. I have been explained about the nature of the study. 
4. I have been explained about my rights and responsibilities by the 
investigator. 
5. I have been informed the investigator of all the treatments I am taking or 
have taken in the past ________ months including any native (alternative) 
treatment. 
6. I have been advised about the risks associated with my participation in this 
study.* 
7. I agree to cooperate with the investigator and I will inform him/her 
immediately if I suffer unusual symptoms. * 
8. I have not participated in any research study within the past 
________month(s). * 
9. I have not donated blood within the past _______ months—Add if the 
study involves extensive blood sampling. * 
10. I am aware of the fact that I can opt out of the study at any time without 
having to give any reason and this will not affect my future treatment in this 
hospital. * 
11. I am also aware that the investigator may terminate my participation in the 
study at any time, for any reason, without my consent. * 
12. I hereby give permission to the investigators to release the information 
obtained from me as result of participation in this study to the sponsors, 
regulatory authorities, Govt. agencies, and IEC. I 
understand that they are publicly presented. 
13. I have understand that my identity will be kept confidential if my data are 
publicly presented 
14. I have had my questions answered to my satisfaction. 
15. I have decided to be in the research study. 
I am aware that if I have any question during this study, I should contact the 
investigator. By signing this consent form I attest that the information given in 
this document has been clearly explained to me and understood by me, I will 
be given a copy of this consent document. 
For adult participants: 
Name and signature / thumb impression of the participant (or legal 
representative if participant incompetent) 
Name _________________________ Signature_________________ 
Date________________ 
 
Name and Signature of impartial witness (required for illiterate patients): 
Name _________________________ Signature_________________ 
Date________________ 
Children being enrolled in research: 
Whether child’s assent was asked: Yes / No (Tick one) 
[If the answer to be above question is yes, write the following phrase: 
You agree with the manner in which assent was asked for /from your child 
and given by your child. You agree to have your child take part in this study]. 
[If answer to be above question No, give reason (s) 
:___________________________________. 
Although your child did not or could not give his or her assent, you agree to 
your child’s participation in this study. 
Name and Signature of / thumb impression of the participant’s parent(s) (or 
legal representative) 
Name _________________________ Signature_________________ 
Date________________ 
Name _________________________ Signature_________________ 
Date________________ 
Name and Signature of impartial witness (required for parents of participant 
child illiterate): 
Name _________________________ Signature_________________ 
Date________________ 
Address and contact number of the impartial witness: 
__________________________________ 
Name and Signature of the investigator or his representative obtaining consent 
:Name _________________________ Signature_________________ 
Date___________ 
 
 
 
 
 
  
 
